Clinical trial

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

NCT07557706

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-15

PhasePHASE1

Study timeline

Study start (actual)2025-09-15Date precision: day

Registry last updated2026-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PARKINSON DISEASE (Disorder)unresolved

Interventions

transcutaneous auricular vagus nerve stimulationDEVICE

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07557706 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.